Salvianolic acid C attenuates cerebral ischemic injury through inhibiting neuroinflammation via the TLR4-TREM1-NF-κB pathway

Wenbo Guo,Xiaojing Xu,Yulin Xiao,Jiatian Zhang,Peiqiang Shen,Xiaoyan Lu,Xiaohui Fan
DOI: https://doi.org/10.1186/s13020-024-00914-0
IF: 4.546
2024-03-14
Chinese Medicine
Abstract:Stroke is a leading cause of mortality and disability with ischemic stroke being the most common type of stroke. Salvianolic acid C (SalC), a polyphenolic compound found in Salviae Miltiorrhizae Radix et Rhizoma, has demonstrated therapeutic potential in the recovery phase of ischemic stroke. However, its pharmacological effects and underlying mechanisms during the early stages of ischemic stroke remain unclear. This study aimed to examine the potential mechanism of action of SalC during the early phase of ischemic stroke using network pharmacology strategies and RNA sequencing analysis.
pharmacology & pharmacy,integrative & complementary medicine
What problem does this paper attempt to address?
This paper aims to explore the treatment mechanism of Salvianolic acid C (SalC) in the early stage of acute cerebral ischemia, especially the mechanism of reducing cerebral ischemia injury by inhibiting neuroinflammation. Specifically, through network pharmacology strategies and RNA - sequencing analysis, the study evaluated the effects of SalC on infarct volume, neurological deficits and pathological changes in a transient middle cerebral artery occlusion (tMCAO) mouse model, and constructed a cerebral ischemia disease (CID) network containing dysregulated genes in the tMCAO model. The study found that SalC significantly reduced the infarct volume, improved neurological deficits, and reversed gene expression in the CID network. Further experiments verified that SalC exerts its anti - inflammatory effect by down - regulating the TLR4 - TREM1 - NF - κB pathway in microglia, thereby reducing cerebral ischemia injury. ### Research Background - **Stroke**: It is one of the leading causes of death and severe disability worldwide, especially ischemic stroke, which accounts for 70 - 80% of all strokes. - **Salvianolic acid C (SalC)**: It is a polyphenolic compound extracted from Salviae Miltiorrhizae Radix et Rhizoma, with antioxidant, anti - inflammatory and anti - apoptotic activities. Previous studies have shown that SalC has therapeutic potential in the late stage of stroke, but its pharmacological effects and mechanisms in the early stage are still unclear. ### Research Objectives - **To explore the treatment mechanism of SalC in the early stage of acute cerebral ischemia**: Especially the mechanism of reducing cerebral ischemia injury by inhibiting neuroinflammation. ### Main Methods - **Animal model**: Use the tMCAO mouse model. - **RNA - sequencing**: Analyze the changes in gene expression in mouse brain tissues before and after SalC treatment. - **Network pharmacology**: Construct a CID network and evaluate the influence of SalC on key nodes in the network. - **Experimental verification**: Verify the changes in key genes and pathways through methods such as qRT - PCR, Western blot, and immunofluorescence staining. ### Main Results - **Reduce infarct volume**: SalC significantly reduced the cerebral infarct volume in tMCAO mice. - **Improve neurological function**: SalC improved the neurological deficits in tMCAO mice. - **Reverse gene expression**: RNA - sequencing results showed that SalC reversed 80% of the gene expression in the CID network, and among them, 53.1% of the genes had a recovery efficiency of more than 50%. - **Inhibit neuroinflammation**: SalC exerts its anti - inflammatory effect by down - regulating the TLR4 - TREM1 - NF - κB pathway in microglia. ### Conclusions - **SalC reduces cerebral ischemia injury by inhibiting microglia - mediated neuroinflammation, especially through the TLR4 - TREM1 - NF - κB pathway**. These findings provide important insights into the potential therapeutic value of SalC in ischemic stroke. ### Keywords - Salvianolic acid C, Cerebral ischemic stroke, Disease network, RNA - transcriptome sequencing, Neuroinflammation, TREM1 Through these studies, the authors hope to provide a theoretical basis for the development of new drugs for the early treatment of ischemic stroke.